Pharmaceutical Online Videos

  1. Flexibility And Scientific Innovation In OSD Development At Our Bend, Oregon Site 8/31/2026

    Watch the video series to see how the right CDMO partner can help anticipate challenges, reduce development risk, and keep your program moving with confidence on the path to market.

  2. Global Complexity Demands Local Resilience 8/31/2026

    With integrated capabilities spanning early development through commercial manufacturing, our U.S. network helps customers build greater supply chain resilience, navigate uncertainty, and create a more reliable path to market.

  3. Thermo Fisher Scientific Capabilities Update August 2026: Oral Solid Dose Formulation 8/25/2026

    Explore proven strategies and end-to-end expertise for overcoming OSD formulation challenges, reducing development risk, and accelerating therapies to patients.

  4. Mikart Capabilities Update August 2026: Oral Solid Dose Formulation 8/24/2026

    Learn how early formulation, analytical, and process decisions reduce scale-up risk, strengthen technology transfer, and support successful oral solid dose commercialization.

  5. Ardena Capabilities Update August 2026: Nanoparticles 8/24/2026

    Explore integrated nanomedicine development, from formulation and analytical testing to GMP manufacturing, scale-up, regulatory strategy, and clinical commercialization.

  6. Sticky Situations: Tackling Residue Inside The Cleanroom With Dave Nobile 8/24/2026

    Learn how to effectively manage chemical residue buildup in cleanrooms through proper solvent selection, dwell time, and mechanical removal to support regulatory compliance.

  7. Recipharm 8/24/2026

    Our development approach is designed to help you move faster from early formulation work to manufacturing readiness and transform complex formulation challenges into more predictable development outcomes.

  8. Alcami Capabilities Update August 2026: Oral Solid Dose Formulation 8/24/2026

    Global pharma companies can improve flexibility by separating blister production from final market packaging, helping balance demand, reduce inventory risk, and meet local

  9. Altasciences Capabilities Update August 2026: Oral Solid Dose Formulation 8/24/2026

    Experts distinguish drug substance from drug product and explore how different molecular modalities—including small molecules, peptides, biologics, and cell therapies—require distinct formulation and dosage form strategies.

     

  10. From Lipids To Launch: End-To-End Therapy Development 8/20/2026

    Explore integrated capabilities spanning lipid manufacturing, nanoparticle formulation, and more with support designed to move complex therapies from preclinical development through commercialization.